| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Ofloxacin measurement |
Component |
True |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ofloxacin adverse reaction (disorder) |
Causative agent (attribute) |
True |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Allergy to ofloxacin |
Causative agent (attribute) |
False |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ofloxacin 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ofloxacin 2mg/mL infusion solution 100mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ofloxacin 2mg/mL infusion solution 50mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ofloxacin 400 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ofloxacin [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ofloxacin 3 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ofloxacin 4mg/mL injection 50mL bag (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ofloxacin 40mg/mL injection 10mL vial (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ofloxacin 4mg/mL injection 100mL bag (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely ofloxacin 300 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely ofloxacin 3 milligram/1 milliliter conventional release ear solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ofloxacin 3mg/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ofloxacin-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ofloxacin-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing ofloxacin in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ofloxacin otic preparation (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ofloxacin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ofloxacin hydrochloride |
Is a |
False |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Allergy to ofloxacin |
Causative agent (attribute) |
True |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ofloxacin 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ofloxacin 200 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ofloxacin 400 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ofloxacin 400 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely ofloxacin 300 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely ofloxacin 300 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ofloxacin 200 mg oral tablet |
Has precise active ingredient |
True |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ofloxacin 400 mg oral tablet |
Has precise active ingredient |
True |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely ofloxacin 300 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ofloxacin hydrochloride |
Is modification of (attribute) |
True |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ofloxacin 3 mg/mL eye drops |
Has basis of strength substance (attribute) |
True |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ofloxacin 3 mg/mL eye drops |
Has precise active ingredient |
True |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely ofloxacin (as ofloxacin hydrochloride) 200 milligram/100 milliliter conventional release solution for infusion bottle |
Has basis of strength substance (attribute) |
False |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely ofloxacin 100 milligram/50 milliliter conventional release solution for infusion bottle |
Has precise active ingredient |
False |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely ofloxacin 100 milligram/50 milliliter conventional release solution for infusion bottle |
Has basis of strength substance (attribute) |
False |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only ofloxacin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ofloxacin only product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only ofloxacin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only ofloxacin in otic dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ofloxacin only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely ofloxacin 2 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
Has basis of strength substance (attribute) |
True |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely ofloxacin 2 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
Has precise active ingredient |
True |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely ofloxacin (as ofloxacin hydrochloride) 2 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
Has basis of strength substance (attribute) |
True |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely ofloxacin 3 milligram/1 milliliter conventional release ear solution (clinical drug) |
Has precise active ingredient |
True |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely ofloxacin 3 milligram/1 milliliter conventional release ear solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely ofloxacin 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely ofloxacin 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely ofloxacin (as ofloxacin hydrochloride) 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely dexamethasone (as dexamethasone sodium phosphate) 1 milligram/1 milliliter and ofloxacin 3 milligram/1 milliliter conventional release eye drops (clinical drug) |
Has precise active ingredient |
True |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing precisely dexamethasone (as dexamethasone sodium phosphate) 1 milligram/1 milliliter and ofloxacin 3 milligram/1 milliliter conventional release eye drops (clinical drug) |
Has basis of strength substance (attribute) |
True |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing only dexamethasone and ofloxacin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing only dexamethasone and ofloxacin in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Dexamethasone- and ofloxacin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Dexamethasone- and ofloxacin-containing product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Ofloxacin- and tinidazole-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only ofloxacin and tinidazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing ofloxacin and tinidazole in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only ofloxacin and tinidazole in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely ofloxacin 200 milligram and tinidazole 600 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely ofloxacin 200 milligram and tinidazole 600 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ofloxacin 10 mg/mL oral suspension |
Has precise active ingredient |
True |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ofloxacin 10 mg/mL oral suspension |
Has basis of strength substance (attribute) |
True |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ofloxacin 200 mg and ornidazole 500 mg oral tablet |
Has precise active ingredient |
True |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ofloxacin 200 mg and ornidazole 500 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only ofloxacin and ornidazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ofloxacin and ornidazole only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ofloxacin- and ornidazole-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing ofloxacin and ornidazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ofloxacin (as ofloxacin hydrochloride) 2 mg/mL solution for infusion and/or injection |
Has basis of strength substance (attribute) |
True |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only cefixime and ofloxacin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Cefixime- and ofloxacin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Cefixime and ofloxacin only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Cefixime- and ofloxacin-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing precisely cefixime 100 milligram and ofloxacin 100 milligram/1 each tablet for conventional release oral suspension (clinical drug) |
Has precise active ingredient |
True |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing precisely cefixime 100 milligram and ofloxacin 100 milligram/1 each tablet for conventional release oral suspension (clinical drug) |
Has basis of strength substance (attribute) |
True |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Ofloxacin 2 mg/mL solution for infusion and/or injection |
Has precise active ingredient |
True |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ofloxacin 2 mg/mL solution for infusion and/or injection |
Has basis of strength substance (attribute) |
True |
Ofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]